Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

Selective RAR-gamma ligands described by Roche

July 21, 1997

Multicenter European clinical trials of REPEL initiated

July 18, 1997

Novel antiinflammatory agents prepared by French investigators

July 17, 1997

Regranex recommended for approval by FDA advisory committee

July 16, 1997

Allergan prepares compounds with retinoid-like activity

July 15, 1997

Interim U.S. phase III results reported for Gliatech's ADCON-L

July 15, 1997

Mechanism of topical absorption of antiandrogen drug investigated

July 15, 1997

New treatment reported for diaper dermatitis

July 15, 1997

Allergan reports agents with retinoid-like activity

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...